The effect of hyperoxygenation on T1 relaxation time in vitro

被引:27
作者
d'Othée, BJ [1 ]
Rachmuth, G [1 ]
Munasinghe, J [1 ]
Lang, EV [1 ]
机构
[1] Beth Israel Deaconess Med Ctr, Dept Radiol, Boston, MA 02215 USA
关键词
oxygen; magnetic resonance imaging; T1 relaxation time;
D O I
10.1016/S1076-6332(03)00004-7
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Rationale and Objectives. Ventilation with high oxygen (O-2) concentrations has been shown to decrease T1 in blood and tissues of patients. This study aims to assess the effect of hyperoxygenation on the T1 relaxation time of blood and other physiologic solutions. Materials and Methods. Varied gaseous mixtures of 0.2 and air between 21% and 100% O-2 were created using an experimental circuit at room temperature, and used to saturate human blood, plasma, or normal saline. The samples were studied using an 8.45-Tesla magnetic resonance (MR) system and a 1.5-Tesla clinical MR scanner. Results. MR spectroscopy at 8.45 Tesla showed that the percentage of O-2 chosen for saturation correlated negatively with T1 (R-2 = 1.00 for blood, 0.90 for plasma, and 1.00 for normal saline). The reduction in T1 between solutions saturated with 21% and 100% 02 was 487 milliseconds (22% of the baseline T1 value) for blood, 391 milliseconds (15,70) for plasma and 622 milliseconds (19%) for saline. Similarly, MR measurements at 1.5 Tesla showed T1 reduction with increasing 02 concentration. Conclusion. The decreasing T1 in blood depends strongly on the fraction of dissolved 02 in solution and is largely independent of the hemoglobin content.
引用
收藏
页码:854 / 860
页数:7
相关论文
共 15 条
[1]   OXYGENATION IN THE RABBIT MYOCARDIUM - ASSESSMENT WITH SUSCEPTIBILITY-DEPENDENT MR-IMAGING [J].
ATALAY, MK ;
FORDER, JR ;
CHACKO, VP ;
KAWAMOTO, S ;
ZERHOUNI, EA .
RADIOLOGY, 1993, 189 (03) :759-764
[2]   Role of dissolved plasma oxygen in hyperoxia-induced contrast [J].
Berkowitz, BA .
MAGNETIC RESONANCE IMAGING, 1997, 15 (01) :123-126
[3]   Determination of optimal injection parameters for intraarterial gadolinium-enhanced MR angiography [J].
Frayne, R ;
Omary, RA ;
Unal, O ;
Strother, CM .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2000, 11 (10) :1277-1284
[4]   Minimizing contrast agent dose during intraarterial gadolinium-enhanced MR angiography: In vitro assessment [J].
Hwang, KP ;
Green, JD ;
Li, DB ;
Simonetti, OP ;
Resnick, SA ;
Finn, JP ;
Duerk, JL ;
Omary, RA .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2002, 15 (01) :55-61
[5]  
Intaglietta M, 1996, CARDIOVASC RES, V32, P632
[6]  
Noseworthy MD, 1999, JMRI-J MAGN RESON IM, V9, P814, DOI 10.1002/(SICI)1522-2586(199906)9:6<814::AID-JMRI8>3.0.CO
[7]  
2-5
[8]   Intraarterial gadolinium-enhanced 2D and 3D MR angiography: A preliminary study [J].
Omary, RA ;
Frayne, R ;
Unal, O ;
Grist, TM ;
Strother, CM .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 1999, 10 (10) :1315-1321
[9]   Determinants of image appearance in contrast-enhanced magnetic resonance angiography - A review [J].
Saloner, D .
INVESTIGATIVE RADIOLOGY, 1998, 33 (09) :488-495
[10]   MRI-guided coronary catheterization and PTCA: A feasibility study on a dog model [J].
Serfaty, JM ;
Yang, XM ;
Foo, TK ;
Kumar, A ;
Derbyshire, A ;
Atalar, E .
MAGNETIC RESONANCE IN MEDICINE, 2003, 49 (02) :258-263